Hypertension as the presenting feature of the antiphospholipid syndrome
| Autor: | G. R. V. Hughes, Muhammad Tungekar, Beverley J. Hunt, Mohammed Yousuf Karim, I C Abbs, P Alba, Munther A. Khamashta |
|---|---|
| Rok vydání: | 2002 |
| Předmět: |
Adult
medicine.medical_specialty Thrombotic microangiopathy 030204 cardiovascular system & hematology Kidney Gastroenterology 03 medical and health sciences 0302 clinical medicine Rheumatology immune system diseases Antiphospholipid syndrome Internal medicine medicine Humans skin and connective tissue diseases 030203 arthritis & rheumatology Pregnancy business.industry Antiphospholipid Syndrome medicine.disease medicine.anatomical_structure Hypertension Immunology Female business |
| Zdroj: | Lupus. 11:253-256 |
| ISSN: | 1477-0962 0961-2033 |
| DOI: | 10.1191/0961203302lu179cr |
| Popis: | The antiphospholipid or Hughes syndrome is the association between antiphospholipid antibodies (aPL), venous and arterial thromboses and pregnancy morbidity.1Antiphospholipid syndrome (APS) commonly coexists with autoimmune diseases usually systemic lupus erythematosus (SLE), when it is known as secondary APS. When present in isolation it is known as primary APS (PAPS). Although the kidney may be affected in APS, its involvement is perhaps not as well described as that of other organs. Thrombotic microangiopathy (TMA) affecting the kidney has been reported as a manifestation in both primary and secondary APS. This report describes hypertension related to underlying renal TMA as a presenting symptom of APS. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|